Melasma mystery: Oral tranexamic acid

---

Original Article

Author Details : Uday Kr Udayan, Pankaj Kr Tiwary*, Ramawatar Singh

Volume : 6, Issue : 3, Year : 2020

Article Page : 254-256

https://doi.org/10.18231/j.ijced.2020.051

Suggest article by email

Get Permission

---

Abstract

Melasma is acquired localized hyper pigmentation of skin characterized by presence of asymptomatic light to dark brown colored macules on malar area, nose, forhead and sometimes chin. Tranexamic acid has been known for its antifibrinolytic effect through the reversible blockade of lysine binding sites on plasminogen molecules and Its usage in the treatment of melasma was accidentally discovered in 1979. Patients were randomly divided into 2 groups, each consisting 70 patients. Group A patients were given oral tranexamic acid 250 mg BD along with SPF 40 sunscreen at daytime and hydroquinone 4% at night. Group B patients
were given only topical treatment same as that of group A. Among group A patients decrement in mean MASI score from baseline was significant at both 12th (9.242.8) and 16th week (8.76 2.3) but not at 8th week (13.41.7), p value was <0> A. Tranexamic acid seems to be potential new medication as in various studies it has been shown to achieve melasma clearance.

Keywords: Trenexamic acid, Melasma, Pigmentation.

How to cite : Udayan U K, Tiwary P K, Singh R, Melasma mystery: Oral tranexamic acid. IP Indian J Clin Exp Dermatol 2020;6(3):254-256

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.